Laura Edgerly-Pflug
Keine laufenden Positionen mehr
Profil
Laura Edgerly-Pflug formerly worked at The Liposome Co., Inc., as Principal, Insmed, Inc., as VP-Technical Operations & Chemistry from 2012 to 2013, OVATION Pharmaceuticals, Inc., as Principal, Lyra Therapeutics, Inc., as Senior Vice President-Technical Operations from 2019 to 2020, Adgero Biopharmaceuticals Holdings, Inc., as VP-Manufacturing Operations & Quality Control from 2016 to 2019, and Pflug Biopharm Solutions LLC, as Owner from 2014 to 2016.
Ms. Edgerly-Pflug received her undergraduate degree from Kean University.
Ehemalige bekannte Positionen von Laura Edgerly-Pflug
| Unternehmen | Position | Ende |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 24.07.2020 |
Adgero Biopharmaceuticals Holdings, Inc.
 Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | Corporate Officer/Principal | 01.06.2019 |
| Pflug Biopharm Solutions LLC | Corporate Officer/Principal | 01.09.2016 |
| INSMED INCORPORATED | Corporate Officer/Principal | 01.12.2013 |
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Corporate Officer/Principal | - |
Ausbildung von Laura Edgerly-Pflug
| Kean University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| LYRA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
OVATION Pharmaceuticals, Inc.
 OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | Health Technology |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | Health Technology |
| Pflug Biopharm Solutions LLC |
